Table I.

The clinicopathologic features of patients with triple negative breast cancer.

Clinicopathologic features	Case (n)	Percent (%)
Age (years)
≥50	25	69.44
<50	11	30.56
Response to emcitabine
Sensitive	21	58.33
Resistant	15	41.67
Tumor size (3 cm)
≥3	12	33.33
<3	24	66.67
TNM stage
I–II	26	72.22
III–IV	10	27.78
Menopause state
Yes	13	36.11
No	23	63.89